Weill Cornell Medical Centers
428 East 72nd Street
New York, New York 10021

Use our guide to learn which trials are right for you!

We've found
2 trials
at this facility
MPN (Myeloproliferative Neoplasms) Clinical Trial
Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272)
Status: Enrolling, Phase II
Updated: 12/31/1969
Weill Cornell Medical Centers
mi
from
New York, NY
Click here to add this to my saved trials
MPN (Myeloproliferative Neoplasms) Clinical Trial
A Study of Itacitinib in Combination With Low-Dose Ruxolitinib or Itacitinib Alone Following Ruxolitinib in Subjects With Myelofibrosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Weill Cornell Medical Centers
mi
from
New York, NY
Click here to add this to my saved trials